Company / Total Assets
AbCellera Biologics Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.4B
FY2025
5-year range
$1.3B / $1.5B
FY2021-FY2025
Trend
-0.3%
vs FY2024
Sector context
#61 of 214
Health Care
What the data says
At $1.4B, AbCellera Biologics Inc.'s total assets ranks #61 of 214 in the Health Care sector. Total Assets has declined for 3 consecutive years, from $1.5B in FY2022 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +6.2%.
Declined from $1.5B to $1.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -4.1%
- 5-Year CAGR
- +6.2%
- 10-Year CAGR
- -
Sector benchmark
#61 of 214 in Health CareTop 29% of 214This company $1.4B Sector average $7.5B
▼
-81.8% below sector average
Key checks
Key Insights
- AbCellera Biologics Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of +6.2%, indicating consistent growth.
- In FY2025, total assets decreased 0.3% year-over-year.
- Ranks #61 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | -0.3% |
| FY2024 | $1.4B | -8.6% |
| FY2023 | $1.5B | -3.4% |
| FY2022 | $1.5B | +16.9% |
| FY2021 | $1.3B | +31.1% |
| FY2020 | $1.0B | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026